P-16

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameP-16
Drug Alias NameP-16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlacental Growth Factor inhibitors
TargetsPlacental Growth Factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSuzhou Stainwei Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuzhou Stainwei Biotech Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A